ATPBD4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.00963723229597E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.2071999944705E-08 |
Normal-vs-Stage2 |
2.231700E-02 |
Normal-vs-Stage3 |
1.11022302462516E-16 |
Normal-vs-Stage4 |
1.63125069008174E-12 |
Stage1-vs-Stage2 |
5.817400E-01 |
Stage1-vs-Stage3 |
1.33310000038911E-07 |
Stage1-vs-Stage4 |
6.37479999999746E-05 |
Stage2-vs-Stage3 |
5.695300E-03 |
Stage2-vs-Stage4 |
1.132390E-02 |
Stage3-vs-Stage4 |
7.609400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.0064171718227E-12 |
Normal-vs-AfricanAmerican |
2.79470000474902E-08 |
Normal-vs-Asian |
5.140200E-03 |
Caucasian-vs-AfricanAmerican |
9.569600E-01 |
Caucasian-vs-Asian |
9.759200E-01 |
AfricanAmerican-vs-Asian |
9.522200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.72695191480443E-12 |
Normal-vs-Female |
9.18209996925157E-09 |
Male-vs-Female |
8.221800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.53630999999432E-05 |
Normal-vs-Age(41-60Yrs) |
1.24340004958867E-09 |
Normal-vs-Age(61-80Yrs) |
1.76647585448109E-12 |
Normal-vs-Age(81-100Yrs) |
1.379800E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.822200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.688200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.421400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.923550E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.309200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.071000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.460100E-03 |
Normal-vs-Grade 2 |
1.53510000044932E-07 |
Normal-vs-Grade 3 |
1.69986247300358E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
8.557000E-01 |
Grade 1-vs-Grade 3 |
1.784950E-01 |
Grade 1-vs-Grade 4 |
3.379000E-03 |
Grade 2-vs-Grade 3 |
3.438400E-03 |
Grade 2-vs-Grade 4 |
8.19669999652106E-08 |
Grade 3-vs-Grade 4 |
2.203700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.20159999955827E-07 |
Normal-vs-ccB subtype |
1.13650000521659E-09 |
ccA subtype-vs-ccB subtype |
6.925800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.75580011535703E-10 |
Normal-vs-N1 |
1.24830001890786E-09 |
N0-vs-N1 |
2.539900E-02 |
|
|